Clincosm LogoSign in Get a demo

neuroendocrine tumors

Showing 26 - 50 of 281
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

Recruiting
  • Neuroendocrine Tumors
  • Carcinoma, Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

    Recruiting
    • Gastroenteropancreatico Tumors
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

    Recruiting
    • Pheochromocytoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized

    Enrolling by invitation
    • Breast Cancer
    • +3 more
    • Copenhagen, Denmark
      Rigshospitalet
    Jan 18, 2023

    Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

    Recruiting
    • Neuroendocrine Tumors
    • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 19, 2023

    Prostate Cancer Metastatic, Neuroendocrine Tumors Trial in Atlanta, Ann Arbor (Pembrolizumab, Lenvatinib)

    Recruiting
    • Prostate Cancer Metastatic
    • Neuroendocrine Tumors
    • Duarte, California
    • +2 more
    Jan 18, 2023

    Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Tampa, Florida
    • +1 more
    Jan 13, 2023

    Neuroendocrine Tumors, Prostate Cancer Trial in Salt Lake City (Single-Tracer FDG PET/CT Exam, Single-Tracer Cu64-DOTATATE

    Recruiting
    • Neuroendocrine Tumors
    • Prostate Cancer
    • Single-Tracer FDG PET/CT Exam
    • +3 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Dec 27, 2022

    Neuroendocrine Tumors Trial in Worldwide (177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, CAPTEM (Capecitabine

    Recruiting
    • Neuroendocrine Tumors
    • 177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT
    • +4 more
    • Palo Alto, California
    • +30 more
    Dec 14, 2022

    Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

    Recruiting
    • Advanced Solid Tumors
    • +11 more
    • Boston, Massachusetts
    • +4 more
    Dec 12, 2022

    Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

    Not yet recruiting
    • Neuroendocrine Tumors
    • +8 more
    • Iowa City, Iowa
    • +1 more
    Nov 23, 2022

    A Real-world Comparison of FNB and FNA in IHC-required Lesions.

    Completed
    • Neuroendocrine Tumors
    • +2 more
    • FNB group
    • FNA group
    • Wuhan, Hubei, China
      Tongji Hospital, Tongji Medical College, HUST
    Nov 26, 2022

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

    Active, not recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +39 more
    • pralsetinib (BLU-667)
    • Phoenix, Arizona
    • +65 more
    Nov 10, 2022

    Neuroendocrine Tumors Trial in Lexington (Telotristat (Low-Dose), Telotristat (High-Dose))

    Recruiting
    • Neuroendocrine Tumors
    • Telotristat (Low-Dose)
    • Telotristat (High-Dose)
    • Lexington, Kentucky
      Markey Cancer Center
    Nov 10, 2022

    DOTATOC PET/CT for Imaging NET Patients

    Recruiting
    • Neuroendocrine Tumors
    • +15 more
    • 68Ga-DOTATOC PET/CT
    • 18F-FDG PET/CT
    • Vancouver, British Columbia, Canada
      BC Cancer
    Nov 2, 2022

    Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)

    Completed
    • Neuroendocrine Tumors
    • +3 more
    • Amino Acid Based Medical Food/Drink
    • Lexington, Kentucky
      University of Kentucky Markey Cancer Center
    Nov 2, 2022

    Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Tumor Trial in Australia (Ipilimumab,

    Recruiting
    • Advanced Biliary Tract Cancer
    • +3 more
    • Albury, New South Wales, Australia
    • +11 more
    Oct 31, 2022

    Neuroendocrine Tumors Trial in United States (Surufatinib)

    No longer available
    • Neuroendocrine Tumors
    • Denver, Colorado
    • +10 more
    Oct 28, 2022

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +3 more
    • 90Y-DOTA tyr3-Octreotide
    • +2 more
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Oct 6, 2022

    Intracranial Glioma, Metastatic Brain Tumor, Breast Cancer Trial in Detroit (1-(2-[18F]FLUOROETHYL)-L-Tryptophan)

    Recruiting
    • Intracranial Glioma
    • +3 more
    • Detroit, Michigan
      Karmanos Cancer Institute
    Sep 22, 2022

    Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)

    Recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Temozolomide capsule
    • Milan, Italy
      European Institute of Oncology, IEO, IRCCS
    Sep 21, 2022

    Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II Trial in Australia (Avelumab, Placebo)

    Recruiting
    • Merkel Cell Carcinoma
    • +5 more
    • Port Macquarie, New South Wales, Australia
    • +17 more
    Aug 30, 2022

    Digestive Cancer, Metastatic Colorectal Cancer, Hepatocellular Carcinoma Trial in France (Blood sampling to build population

    Recruiting
    • Digestive Cancer
    • +4 more
    • Blood sampling to build population pharmacokinetics model
    • Auxerre, France
    • +23 more
    Aug 30, 2022

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022